Cricut vs Kadant
CRCT and KAI side by side, both in special industry machinery, except metalworking. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CRCT and KAI compare
Kadant is the larger company, worth 1.9 times as much as Cricut ($3.5B against $1.8B).
On earnings, Cricut is cheaper: it trades at 19.2× trailing earnings, against 29.7× for Kadant.
Kadant grew revenue faster over the last twelve months (16.6% versus −0.91% for Cricut).
Cricut keeps more of each dollar of sales as profit, with a net margin of 13.4% compared with 9.8% at Kadant.
Both pay dividends: Cricut yields 2.3% and Kadant 0.48%.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CRCT | KAI |
|---|---|---|
| Size and price | ||
| Market cap | $1.8B | $3.5B |
| Share price | $8.65 | $294.21 |
| Change, 1 year | 82.1% | 10.9% |
| Change, 5 years | −65.0% | 25.3% |
| Beta (5Y) | 0.99 | 1.00 |
| Employees | 700 | 3,900 |
| StockData Score | ||
| Total score | 19 | 19 |
| Valuation score | 4 (better) | 3 |
| Growth score | 2 | 3 (better) |
| Performance score | 5 (better) | 4 |
| Health score | 6 (better) | 5 |
| Dividend score | 2 | 4 (better) |
| Valuation | ||
| P/E | 19.2× (better) | 29.7× |
| P/S | 2.6× (better) | 2.9× |
| P/B | 4.5× | 3.3× (better) |
| EV/EBITDA | 10.8× (better) | 15.5× |
| P/FCF | – | 20.0× |
| PEG | 2.49 | – |
| FCF yield | – | 5.0% |
| Fair value | $11.12 | $283.20 |
| Margin of safety | 22.2% (better) | −3.9% |
| Growth | ||
| Revenue growth (TTM) | −0.91% | 16.6% (better) |
| Revenue growth, 5Y average | −5.9% | 10.6% (better) |
| Net income growth (TTM) | 17.5% (better) | 14.8% |
| EPS growth (TTM) | 18.4% (better) | 14.5% |
| EPS growth, 5Y average | −13.9% | 12.6% (better) |
| Profitability | ||
| Gross margin | 58.5% (better) | 44.4% |
| Operating margin | 16.7% (better) | 15.4% |
| Net margin | 13.4% (better) | 9.8% |
| FCF margin | – | 14.6% |
| Return on equity | 25.1% (better) | 11.7% |
| Return on invested capital | 63.3% (better) | 10.8% |
| Financial health | ||
| Debt / equity | 0.00 | 0.43 (better) |
| Net debt / EBITDA | – | 1.31 |
| Interest coverage | 254× (better) | 8.9× |
| Current ratio | 2.40 | 2.49 (better) |
| Altman Z-score | 6.78 (better) | 4.53 |
| Piotroski F-score | 7 (better) | 5 |
| Dividends and buybacks | ||
| Dividend yield | 2.3% (better) | 0.48% |
| Payout ratio | 44.3% | 14.1% |
| Years of dividend growth | – | 13 |
| Dividend growth, 5Y average | – | 7.2% |
| Buyback yield | 1.7% (better) | −0.07% |
| Shareholder yield | 4.0% (better) | 0.41% |
| Ownership | ||
| Held by institutions | 14.3% | 111% |
| Held by insiders | 75.9% | 1.2% |
| Insider net buying, 12 months | −$9.3M | −$861K (better) |
| Short interest, % of float | 9.6% | 6.8% |
Go deeper
- CRCT stock overview
- CRCT income statement
- CRCT valuation and score
- KAI stock overview
- KAI income statement
- KAI valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.